Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (GRAIL)

This study is currently recruiting participants.

Verified April 2013 by Fred Hutchinson Cancer Research Center

Sponsor:

Collaborators:

Genentech

Information provided by (Responsible Party):

Fred Hutchinson Cancer Research Center

ClinicalTrials.gov Identifier:

NCT01335932

First received: April 13, 2011

Last updated: April 26, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2014
Estimated Primary Completion Date:	August 2014 (Final data collection date for primary outcome measure)